- Commentary : Sustained reduction in disability progression in patients with primary progressive multiple sclerosis - follow-up study ORATORIO2020 | Faculty of Medicine in Pilsen
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis2012 | First Faculty of Medicine
- Confirmed disability progression as a marker of permanent disability in multiple sclerosis2022 | First Faculty of Medicine
